499 related articles for article (PubMed ID: 12080476)
21. Loss of heterozygosity analysis of a candidate gastric carcinoma tumor suppressor locus at 7q31.
Xia JC; Weng DS; Li JT; Qin HD; Mai SJ; Feng BJ; Fan Q; Feng QS; Huang LX; Yu XJ; Pan ZZ; Li YQ; Wang QJ; Zhan YQ; Chen SP; He J; Huang WL; Wu PH; Zeng YX
Cancer Genet Cytogenet; 2006 Apr; 166(2):166-72. PubMed ID: 16631475
[TBL] [Abstract][Full Text] [Related]
22. [Loss of heterozygosity on chromosome 9p13-23 in microdissected laryngeal squamous cell carcinoma by microsatellite analysis].
Xu X; An Q; Zhang J; Tang P; Cheng S
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2001 Oct; 36(5):367-71. PubMed ID: 12761947
[TBL] [Abstract][Full Text] [Related]
23. Frequent loss of chromosome 9p21-22 early in head and neck cancer progression.
van der Riet P; Nawroz H; Hruban RH; Corio R; Tokino K; Koch W; Sidransky D
Cancer Res; 1994 Mar; 54(5):1156-8. PubMed ID: 8118798
[TBL] [Abstract][Full Text] [Related]
24. A simple specific pattern of chromosomal aberrations at early stages of head and neck squamous cell carcinomas: PIK3CA but not p63 gene as a likely target of 3q26-qter gains.
Redon R; Muller D; Caulee K; Wanherdrick K; Abecassis J; du Manoir S
Cancer Res; 2001 May; 61(10):4122-9. PubMed ID: 11358835
[TBL] [Abstract][Full Text] [Related]
25. Molecular characterization of head and neck tumors by analysis of telomerase activity and a panel of microsatellite markers.
Fiedler W; Hoppe C; Schimmel B; Koscielny S; Dahse R; Bereczki Z; Claussen U; Ernst G; von Eggeling F
Int J Mol Med; 2002 Apr; 9(4):417-23. PubMed ID: 11891539
[TBL] [Abstract][Full Text] [Related]
26. Genetic alterations of chromosome band 9p21-22 in head and neck cancer are not restricted to p16INK4a.
Waber P; Dlugosz S; Cheng QC; Truelson J; Nisen PD
Oncogene; 1997 Oct; 15(14):1699-704. PubMed ID: 9349503
[TBL] [Abstract][Full Text] [Related]
27. Lymph node metastasis is associated with allelic loss on chromosome 13q12-13 in esophageal squamous cell carcinoma.
Harada H; Tanaka H; Shimada Y; Shinoda M; Imamura M; Ishizaki K
Cancer Res; 1999 Aug; 59(15):3724-9. PubMed ID: 10446988
[TBL] [Abstract][Full Text] [Related]
28. Fhit expression is absent or reduced in a subset of primary head and neck cancer.
Götte K; Hadaczek P; Coy JF; Wirtz HW; Riedel F; Neubauer J; Hörmann K
Anticancer Res; 2000; 20(2A):1057-60. PubMed ID: 10810397
[TBL] [Abstract][Full Text] [Related]
29. Downregulation of RAD17 in head and neck cancer.
Zhao M; Begum S; Ha PK; Westra W; Califano J
Head Neck; 2008 Jan; 30(1):35-42. PubMed ID: 17657792
[TBL] [Abstract][Full Text] [Related]
30. Characterization of the human TESTIN gene localized in the FRA7G region at 7q31.2.
Tatarelli C; Linnenbach A; Mimori K; Croce CM
Genomics; 2000 Aug; 68(1):1-12. PubMed ID: 10950921
[TBL] [Abstract][Full Text] [Related]
31. Impact of chromosome 14q loss on survival in primary head and neck squamous cell carcinoma.
Lee DJ; Koch WM; Yoo G; Lango M; Reed A; Califano J; Brennan JA; Westra WH; Zahurak M; Sidransky D
Clin Cancer Res; 1997 Apr; 3(4):501-5. PubMed ID: 9815712
[TBL] [Abstract][Full Text] [Related]
32. Absence of ST7 gene alterations in human cancer.
Dong SM; Sidransky D
Clin Cancer Res; 2002 Sep; 8(9):2939-41. PubMed ID: 12231539
[TBL] [Abstract][Full Text] [Related]
33. Loss of heterozygosity in human primary prostate carcinomas: a possible tumor suppressor gene at 7q31.1.
Zenklusen JC; Thompson JC; Troncoso P; Kagan J; Conti CJ
Cancer Res; 1994 Dec; 54(24):6370-3. PubMed ID: 7987830
[TBL] [Abstract][Full Text] [Related]
34. RAR beta2 suppression in head and neck squamous cell carcinoma correlates with site, histology and age.
Olasz J; Juhász A; Remenár E; Engi H; Bak M; Csuka O; Kásler M
Oncol Rep; 2007 Jul; 18(1):105-12. PubMed ID: 17549354
[TBL] [Abstract][Full Text] [Related]
35. Defining a common region of deletion at 13q21 in human cancers.
Chen C; Brabham WW; Stultz BG; Frierson HF; Barrett JC; Sawyers CL; Isaacs JT; Dong JT
Genes Chromosomes Cancer; 2001 Aug; 31(4):333-44. PubMed ID: 11433524
[TBL] [Abstract][Full Text] [Related]
36. Loss of heterozygosity at the 9p21-24 region and identification of BRM as a candidate tumor suppressor gene in head and neck squamous cell carcinoma.
Gunduz E; Gunduz M; Ali MA; Beder L; Tamamura R; Katase N; Tominaga S; Yamanaka N; Shimizu K; Nagatsuka H
Cancer Invest; 2009 Jul; 27(6):661-8. PubMed ID: 19488910
[TBL] [Abstract][Full Text] [Related]
37. Dominant negative p63 isoform expression in head and neck squamous cell carcinoma.
Sniezek JC; Matheny KE; Westfall MD; Pietenpol JA
Laryngoscope; 2004 Dec; 114(12):2063-72. PubMed ID: 15564824
[TBL] [Abstract][Full Text] [Related]
38. Evidence for three tumor suppressor loci on chromosome 9p involved in melanoma development.
Pollock PM; Welch J; Hayward NK
Cancer Res; 2001 Feb; 61(3):1154-61. PubMed ID: 11221846
[TBL] [Abstract][Full Text] [Related]
39. An allelotype of squamous carcinoma of the head and neck using microsatellite markers.
Ah-See KW; Cooke TG; Pickford IR; Soutar D; Balmain A
Cancer Res; 1994 Apr; 54(7):1617-21. PubMed ID: 8137268
[TBL] [Abstract][Full Text] [Related]
40. Allelic loss at 7q31.1 in human primary ovarian carcinomas suggests the existence of a tumor suppressor gene.
Zenklusen JC; Weitzel JN; Ball HG; Conti CJ
Oncogene; 1995 Jul; 11(2):359-63. PubMed ID: 7624150
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]